Innovative Trial Approaches in Immune-Mediated Inflammatory Diseases: Current Use and Future Potential (2020)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-63613/v1
Publication URI: http://dx.doi.org/10.21203/rs.3.rs-63613/v1
Type: Preprint